General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2)
|
|
|
- えつま そめや
- 7 years ago
- Views:
Transcription
1
2 General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2)
3 (3) (4) (Standard Precautions ) (5) ( )
4 (6) (7) ( ) ( ) QOL(Quality of Life) ( ) (8) 1
5 2 (1) (2) (3) 4 24 (4) 3 ABC3
6 (common disease) up to datepub medbest evidence 20
7 common disease up to date pub med best evidence CDROM
8
9 A CTMRI MRI B
10 C
11 D QOL
12 1. () () () () () X CT () () () () () () () () () () () NIPPV () () () ()
13 () () () () () () () () () () () ()
14 () () () () ()
15
16
17 SB EISEVL EMRESTEPD TAEPEIT PBC, PSS 4.
18
19
20
21 A Na Na 5 K K sick day IgA
22 B CT,MRI 13 IC 14 6
23 1) 2) 3) 4) 5)
24 ) ) 3) ) 5) 6)
25 ABC3
26 () () () (DIC) PAIgG ()
27 () in situ hybridization(ish) () () CT MRI B (Hodgkin non-hodgkin ) graft-versus-host disease(gvhd) (AIDS)
28 B12 EPO, G-CSF Donor lymphocyte infusion(dli) plasmapheresis cytapheresis(leukapheresis) CD20
29 A Oncologic emergency
30 () () () SOAP () () () () () ()
31 ()
32 1) 2) 3) 4) 5) 6) 7) 8) 9) 10) 11) 12) 13) 14) QOL
33 15) 16) 17) 18) 19) 20) (A) (B) (C) (A) (B) (B) (B) (A) (A) 12 (A) (B) (A)
34 (B) (A) (B) PCR (B) (A) (B) (B) (A) (C) (A) (C) (B) (B) CT (B) (C) MRI (C) (C) (C) 20) 21)
35 22) CPC (1) (2) (3) (4) (5) (6) (7)
36 (8) 1 (9) (10) ABC3
37 X X CT MRI
38 70
39 3 A, B, C A B C 70
40 + + +
41 ()
42 () 4 ()
43 ABC3
44 (MMT) (ROM) (ADL) X scan (EMG) ( )
45 ( ) () () ABC3
46
47
48 6
49 QOL () () Leopold Apgar ScoreSilverman score A B () A A
50 A B () A A () A () A A A () A A () B B B () B B CT A MRI A B () () 5 () () 5 ()
51 () () () () () () () () () () () CTMRI () () () () ()
52 () ()
53
54
55
56
57
58 1) 2)
59 3) 4) 5) 6) ABC3
60 KUBIVP CTMRI 57
61 ESWL 1) 2) 3) 4) 5)
62 ABC3
63
64
65
66
67
68 70
69
70 HBsAg HCV HIV1/2 TP 2. A RS in situ hybridization 4. 5.
71 ) 1 4 2
72
73
74
75
76
77
78
79
80
81
82
83
84
85
障害者職域拡大カリキュラム研究会中間報告書構成案
3 4 5 5 7 7 9 () 9 ()23 34 1 36 47 49 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ADL QOL 36 37 38 39 40 41 42 43 44 45 46 16 8 () 19 ( ) () 21 () 47 16
Microsoft Word - Ｈ22年度雄勝中央病院卒後臨床研修プログラム.docx
3 2 380 32 1 202,812 11,967 17.2 1,441 129 24 1 6 1 3 1 2 3 50-60 /2 2 2 1-2 2 1 2 2 1 1-2 1 CPC / 4 / / 2 / AED ICLS JPTEC 3 a: b: c: d: 4 c,d a b d 70% 2 10 4 11 12 21 7 21 8 5 Evidence Based Medicine
4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2
5 2006 9 1 A) 1 2 3 4 B) 1 2 3 4 5 2 A) GDP 7.9 B) 31 25 8 10 1 45 3 31 8 2 70 1 4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2 1.6 3 31.1 4 2 5 3 4 CT MRI PET 1 30 A) 1 2 6 B) 1 2 3 4 5 3 90.5
1 2 3 4 5 6 X Y ABC A ABC B 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 13 18 30 P331 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ( ) 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
26 2 3 4 5 8 9 6 7 2 3 4 5 2 6 7 3 8 9 3 0 4 2 4 3 4 4 5 6 5 7 6 2 2 A B C ABC 8 9 6 3 3 4 4 20 2 6 2 2 3 3 4 4 5 5 22 6 6 7 7 23 6 2 2 3 3 4 4 24 2 2 3 3 4 4 25 6 2 2 3 3 4 4 26 2 2 3 3 27 6 4 4 5 5
mogiJugyo_slide_full.dvi
a 2 + b 2 = c 2 (a, b, c) a 2 a 2 = a a a 1/ 78 2/ 78 3/ 78 4/ 78 180 5/ 78 http://www.kaijo.ed.jp/ 6/ 78 a, b, c ABC C a b B c A C 90 a 2 + b 2 = c 2 7/ 78 C a b a 2 +b 2 = c 2 B c A a 2 a a 2 = a a 8/
-2-
Super Lizer HT-2200 m m W Super Lizer -1- -2- -3- -4- stellate ganglion block stellate ganglion -5- -6- -7- -8- IgA -9- " " -10- -11- 5 6 10 1-12- -1- -2- mv -3- -4- -5- -1- : -2- No.2576 P.25 1973-3-
untitled
C08036 C08037 C08038 C08039 C08040 1. 1 2. 1 2.1 1 2.2 1 3. 1 3.1 2 4. 2 5. 3 5.1 3 5.2 3 6. 4 7. 5 8. 6 9. 7 10. 7 11. 8 C08036 8 C08037 9 C08038 10 C08039 11 C08040 12 8 2-1 2-2 T.P. 1 1 3-1 34 9 28
長崎県県央保健所事業概要
P1 P2~P3 P4 P5 P7~P10 P11~P40 P41~P174 P175~P179 P181~P212 271,417 2 3 4 5 5 7 8 9 10 12 13 14 15 16 18 19 2,506 365 293 5 20 2 4 123 4 17 1 2 143 351 5 3 18 40 10 475 3 2 22 22 66 1 13 18 31 10
無印良品のスキンケア
2 3 4 5 P.22 P.10 P.18 P.14 P.24 Na 6 7 P.10 P.22 P.14 P.18 P.24 8 9 1701172 1,400 1701189 1,000 1081267 1,600 1701257 2,600 1125923 450 1081250 1,800 1125916 650 1081144 1,800 1081229 1,500 Na 1701240
untitled
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 -
11 第25回がん学会一般演題一覧（第3会場）
1) 2) 1) 2) KTSND 2 200 KTSND KTSND 2014 4 CD56 Chromogranin Ki67 70% CT T2N4M0stage IVa /(egfr 55ml/min Cre 1.05mg/dl)/ PR 12 2015 4 CT 6 62 20XX 6 CTMRI 5 7 10 DIC methotrexatemtx /5-FU DIC score ALP
FdData社会地理
[ [ 1(3 ) [ 2(3 ) A C [ [ [ 3(2 ) (1) X Y Z (2) X Y Z 3,000m [ 4(3 ) [ [ [ 5(2 ) ( ) 1 [ [ 6( ) (1) A (2) (1) B [ 7(3 ) (1) A (2) A (3) A 2 [ 8(2 ) [ 9(3 ) 2 [ 10(2 ) A H [ [ 11( ) A H 3 3 [ 12(2 ) [ (
消防力適正配置調査報告
8 5 5 20 11 22 4 25 1.1 1 1.2 1 1.3 2 2.1 6 2.2 6 2.3 8 2.4 8 2.5 9 3.1 10 3.2 10 3.3 13 4.1 15 4.2 17 4.3 19 4.4 21 4.5 23 (1) - 1 - (2) (1) ()1 ( ) 8 1 1 143 116 (2) 1-2 - 26 24 19 24 6 21 24 4 19 24
Microsoft Word - 01Ł\”ƒ.doc
226821,416* 13,226 22 62,640 46,289 13,226 28.6 * 8,030 4,788 408 13,226 2,249 2,868 55 5,173 2,153 716 93 2,962 3,628 1,204 260 5,092 173 10 361 25.5% 40 220 112 50.9% 4,922 804 16.3% 3040 141 54 38.3%
「東日本大震災に係る対応―保険診療・地域医療再生基金・災害復旧費補助金・医療法等について（第1報）」について
2012 3 28 2011 3 1 1 2012 3 2012 3 28 2012 3 28 2012 3 28 2012 3 28 1. 1 3 11 1 2 3 15 17 3 4 5 1 2012 3 28 5 10 6 3 18 7 5 8 3 23 9 2 2012 3 28 2011 3 23 23 10 3 2012 3 28 4 2012 3 28 5 2012 3 28 3 24
17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) (1) (3) 25. (1) (3) 26. (1) 27. (1) (3) 28. (1) 29. (1) 2
1. (1) 2. 2 (1) 4. (1) 5. (1) 6. (1) 7. (1) 8. (1) 9. (1) 10. (1) 11. (1) 12. (1) 13. (1) 14. (1) 15. (1) (3) 16. (1) 1 17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) 24. 1 (1) (3)
1 5 6 2 3 7 8 4 5 9 10 6 7 11 12 8 1 2 3 4 5 6 7 1989 25.0% 19901999 6 2000 15.0% 9 13 1 2 3 4 5 50 2 5180 45.0% 81 35.0%, 5.0% + +, 5.0% +, 1, 5 +, 3 14 10 0% 20% 40% 60% 80% 100% n=20 3 5 2 n=20 55.0%
2
1 2 3 1) 2) 3) 2 3 1 2 3 4 5 6 7 8 9 10 11 4 12 13 14 15 X 16 X 17 X CT 18 MRI 19 20 4 A. ENG T&T B. ABLB SISI ABR ASSRMLRSRL 5 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 6 1 2 3 4 7 1 POS( Problem
2017 978-4-560-01288-1 http://www.hakusuisha.co.jp/ Contents 6 20 26 33 37 39 41 44 57 7377 2 3 5 49 53 55 2 3 4 5 6 OK CD 3 5 2 8 2 7 8 9000 3 8 68000 32 9 CD CD CD 1511 CD! 10 2 CD?! CD 11 12 3600 10,000
10K1A NASA () SPACE ATLAS Freedom H2A NASA 1
10O1A 10 10 1 10K1A NASA () SPACE ATLAS 40 1957 1969 10 1986 1990 Freedom 20 000 H2A NASA 1 10K1A 100 10 21 40 1996 ( 200 () 2 10S1A 10 8 57 250 1 10S1A 20 200mmm 2 10S1B 18 18 1 10S1B 40 10 20 2 10S1C
104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26
25 25 3 5 MMR 1 104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 2012 8 31 1,032,660 132 ( 0.013 ) 3 2010 6 11 3 11 15.4 1 1 ( ) 12 2 2 3 ER ) (
NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml
NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008
200 30 984 1 1854 1713 1000 1008 ED ADL/QOL The European Working Group on Sarcopenia in Older People EWGSOP Asian Working Group for Sarcopenia AWGS D C Zhang, 2006 C Imamura, 2008 ATP Imamura, 2009 Imamura,
エンジョイ北スポーツ
2772083130 83 1 2 3 4 5 6 7 8 2 2 2 3 3 4 4 6 7 8 1211 53 /15,171 /509 /670 /13,992 2 83130 http://www.kita-city-taikyo.or.jp 83130 http://www.kita-city-taikyo.or.jp 3 68 35 45 4 83130 http://www.kita-city-taikyo.or.jp
1 2 2 10 4 4 6 7 8 8 9 9 9 9 10 11 11 13 13 15 15 15 15 15 16
1 2 2 10 4 4 6 7 8 8 9 9 9 9 10 11 11 13 13 15 15 15 15 15 16 16 16 16 16 16 16 17 17 17 17 18 18 18 18 18 19 19 19 19 15 2 10 IT 10 16 11 21 1 23 6 5 23 6 1 18 3 24 12 (1)(2)(3) (4) (5)(6) 18 8 24 12
INSメイトV30Slim取扱説明書（5版2008.3）
79 1 CD-ROM 80 1 Internet 81 1 8 8 1 1 5 6 8 1 7 85 1 86 1 5 6 87 1 88 89 1 5 6 1 90 1 5 6 7 91 8 9 10 11 9 1 1 1 1 9 15 16 17 9 1 18 19 95 1 96 1 97 1 98 1 5 99 6 7 8 100 1 1 101 5 6 10 1 10 10 1 105
QOL 02 QOL QOL UI AI EAThoracotomy TTThoracoscopy TS QOL EA type-c y score UI 3 AI 8 School score QOL score 12
54 1 2018 2 4-1 OK-432 1 15 14 15 US CT MRI 17 cm 0.16 g/kg/day OK-432 3 1 ke 2 2 ke 3 1 1,150 ml 13 US OK-432 4-2 TJ-28 TJ-28 2003 3 2017 6 250 TJ-28 44 16 28 TJ-28 7 2 46 8.5 2 2 9 34 79.1 10 23.3 34
東京で独立開業する。～独立開業マニュアル東弁版～
26 2010 2012 1 2013 2 2014 4 2006 2010 2015 2015 2013 2012 2012 2014 2012 2012 2014 2010 2015 / 2014 2013 2012 2014 2014 2014 2015 2015 2014 2014 2010 2009
11夏特集号初校.indd
1 2 3 5 50 40 7 6 3 ABC 3 5 A 5% B C 100 3 1 2 3 A 5% 5% 5% B 10% 5% 0% C 20% 10% 15% A 15.8% 15.0% 0.8% B 15.5% 15.0% 0.5% C 12.2% 15.0% 2.8% 2,000 1,500 1,000 500 0 10% 5% 3% 1% 01 5 10 15 20 25 30
MRI
13 13 14530 1 2 3 5157 6 6 24 52 865 1385 7 MRI 14 27 13 13182 37 3328 595 2374 3097 34726 1157 38 9 13 2604 13 29823 13 84629 417 354 4295 246 37 22452 2726 13 242 26.5% 1.8% 920 2374 62177 1445 13 12
PSCHG000.PS
NST FA X in in % X P http:w ww2.miyazaki.m ed.or.jp:xoops LED LED LED LED LED LED LED LED LED LED evt evtvt e IgM e e e PCR e RS e e e e e e e PR HDL LD L DiG eorge Chediak-Higashi Potter basic
C79 A11 A12 A13 A19 B11 B12 B13 B14 B15 B19 B21 B22 B23 B24 B25 C11 C12 C19 C21 C31 C32 C33 C34 C35 C36 C37 C39 C41 C51 C52 C53 C54 C55 C61 ( ) C62 C6
C79 A11 A12 A13 A19 B11 B12 B13 B14 B15 B19 B21 B22 B23 B24 B25 C11 C12 C19 C21 C31 C32 C33 C34 C35 C36 C37 C39 C41 C51 C52 C53 C54 C55 C61 ( ) C62 C63 C64 C71 C72 C73 C74 C99-1 - A11 A12 1 1 A13 A19 11
PSCHG000.PS
FA X P.S. B5 A4 A4 B5 B4 A3 A4 A4 PR A4 B5 A4 A4 A4 B5 A4 A4 B5 FA O TEL& FAX H GF a NHS NHS NHS HM O e NICU NICU TEL Common disease Brugada BrugadaVTVf Brugada Brugada V coved saddleback
untitled
7/67/1073,42911 15,020158,393 7/127/184,6674,913 2927 71.3 894 21.8 287 7.0 n=4108) 132 3.2 62 1.5 934 22.7 786 19.1 629 15.3 801 19.5 407 9.9 357 8.7 (n=4108) 35 35 30 25 20 15 10 153 3.7 1 0.02 23 0.6
1 3 4 5 6 1987 1 4 5 5 17 1997 2 30 30 ROM 9 45 3 2001 56 1 RS232 Windows95Windows98Mac ON/OFF Windows95 Windows98 QOL 1 2 5 2 1996 3 HANDITEK CEDAKO 1997 10 1 1999 5 4 9 11 9 5 5 PIC 3 400 1000 1999
エンジョイ北スポーツ
2672080127 3 1 2 3 2 3 4 4 5 5 5 7 8 4 5 6 7 8 1411 55/14,817 /259/655/13,903 2 80127 http://www.kita-city-taikyo.or.jp TOKYO TOKYO 80127 http://www.kita-city-taikyo.or.jp 3 4 80127 http://www.kita-city-taikyo.or.jp
untitled
5 10% 1 13 15cm 3 4cm 2 RS P Rb Ra S RS Ra Rb P 4 S RS CT MRI Stage 0 Stage I Stage I Stage II Ra Rb P TEM TEM ISR TEM Transanal endoscopic microsurgery 5cm 4cm 5cm TEM 1 2 3 10cm RS 6cm Ra 4cm Rb 2cm
DiMAGE Scan Elite 5400II
SCAN ON/OFF EJECT FOCUS ON/OFF SCAN EJECT FOCUS SCAN EJECT FOCUS 1 2 3 4 PULL UP 5 6 PULL UP UP 1 2 4 UP 3 PULL PULL PULL UP UP UP 1 2 3 4 1 2 4 UP 3 PULL PULL 2 3 4 2 3 ON/OFF SCAN EJECT FOCUS
A 01 2 015 10 11 12 G 011 2 0111 67
66 A 01 2 015 10 11 12 G 011 2 0111 67 0119 0112 0113 68 0130 0128 0114 0113 0115 0116 0119 69 0111 0128 012 2 0121 1102 0122 0123 0124 70 0125 0126 0126 0111 0127 71 0128 0129 0230 013 0130 0130 011 012
Microsoft Word - 倫理 第40,43,45,46講 テキスト.docx
6 538 ( 552 ) (1) () (2) () ( )( ) 1 vs () (1) (2) () () () ) ()() (3) () ( () 2 () () () ()( ) () (7) (8) () 3 4 5 abc b c 6 a (a) b b ()() 7 c (c) ()() 8 9 10 () 1 ()()() 2 () 3 1 1052 1051 () 1053 11
添付資料２.PDF
CD-ROM 7 29 29 33 15 3 12 2 5 6 2 PC 100 40 FAX 1 9 1 3 3 10Km AMeDAS 17Km 2 FAX LAN OEM 1 50 50 10 20 T 1 POS 2 10 7 12 7 3 17 18 85 90 20 22 23 25 CD- ROM 10 km X1 3 1 % 3 3 6 1 FAX 6 2 1 3 2 3 3 6
------------------ ------------------ ------------------------------ ------------------------------ ------------------------------ -------------------
CDC TEL FAX ------------------ ------------------ ------------------------------ ------------------------------ ------------------------------ ------------------------------ --------------- ---------------
4 1 2 34 56 1
2016 8 2 2 4 1 2 34 56 1 3 2 4 2 78 910 2 1 3 10,000 A 100 A 9,900 9,900 A 100 100 POINT! 4 2 2 2 5 2100 100 3 50 5050100 POINT! 6 3 2 7 ABC 2 10010,0001100 2 100 2 5,000 1 50 32 16,000 13,000 10,000 7,000
表1.eps
Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol
CD PAC CKD M RT AI TPP K orotkoff K orotkoff O VT O VT DIC AIDS RS RS RS AH3 A10 A16 RS B ordetella pertussis O 111 O111H VT12 O121H 19 VT2 O 20H 6 eae O55H 7 eae O 145H UT eae Salm onella O7r5
pp doi: /jjsps.54.6_ The 34th Autumn Symposium of The Japanese Society of Pediatric Surgeons
54 6 2018 10 pp. 1173-1193 doi: 10.11164/jjsps.54.6_1173 1173 34 The 34th Autumn Symposium of The Japanese Society of Pediatric Surgeons 30 2018 10 27 10-1 3-6-2 HP URL https://psjm2018.com/ 34 PSJM2018
INSメイトV30Slim 取扱説明書（1版2001.10）
3 4 5 6 7 8 9 3 0 4 5 3 4 5 6 7 3 4 5 6 P40 P73 P84 P86 P P96 P3 P93 P05 P89 7 P4 P P88 P37 P0 P P9 8 9 CD-ROM 0 CD-ROM 8 7 3 4 5 6 80 3 4 3 4 3 4 900700 3 4 00-097 5 6 3 7 8 9 5 4 3 30 3 3 3 3 33 35
エンジョイ北スポーツ
2881086133 http://www.kita-city-taikyo.or.jp 86 5 5 5 6 1 2 3 4 5 6 7 8 1915 54 /15,166 /568 /688 /13,910 2 86133 http://www.kita-city-taikyo.or.jp NTC 86133 http://www.kita-city-taikyo.or.jp 3 4 86133
13 1 17 1942 1980 7 1 1 2
É 22(1889) 2 5(1916) 3 478 478 518 478 4 CD-ROM 1 75 171 301 347 CD-ROM É 1 13 1 17 1942 1980 7 1 1 2 CD-ROM 1990 22 2 23 5 16 3 22 4 1 110 29 3 193 193 32 7 195 32 8 193 195 32 5 19 11 32 13 21 44 10
GL改訂_野原班DST.indd
Quality of Life QOL HRQL Circulation Journal Vol. 71, Suppl. IV, 2007 1 HRQL ASO ASO ASO ASO 2 Circulation Journal Vol. 71, Suppl. IV, 2007 evidence based medicine a a b A B C,, A Quality of LifeQOL HDL
untitled
-1-2 1 1-1 -2 2 2 3 3 4 5 10-2- http://www.jsps.go.jp/j-grantsinaid/index.html -3- -4- -5- -1 4-6- -7- -8- -9- -10- CD-ROM DVD-ROM CD-ROM DVD-ROM CD-ROM DVD-ROM 1-3 2-1 1-3 2-1 -11- -12- CD-ROM DVD-ROM
平成１７年度 マスターセンター補助事業
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - IC IC - 29 - IT
PSCHG000.PS
JA W S CT CT FA X P ab PC Levitin BA ADL QOL ADL QOL NEW ENGLISH READINGS book tw o. T he P ressp Bluetooth Bluetooth B COM Bluetooth Class Bluetooth GHz Bluetooth Class ClassClassClass H arald
2
1 2 17 1884 2 131 1 1..He lived to serve 2 2 2 2 14,416 104,000 1 QOL Quality of Life 2 21 2013 25 21 3 4 5 QOL 6 QOL QOL 59 1 60 7 QOL QOL 8 2,774 2015 27 5 7 241 2015 27 5 8 12 2015 3 7 58 1,030 113
在外教育施設派遣教員安全対策資料 在外教育施設派遣教員安全対策資料
1. 1. 1.1.1. 1.1.2. 1.1.3. 1.1.4. 1.1.5. 1. 2. 1. 3. 1. 4. 1-1 1-2 1-3 2. 1. 2. 2. 2. 3. 2. 4. 2.4.1. 2.4.2. 2-1 2. 5. 2. 6. 2.6.1. 2.6.2. 2.6.3. 2.6.4. 2.6.5. 2. 7. 2.7.1. 2.7.2. 2.7.3. 2.7.4. 2. 8. 2.
パネルディスカッション「図書館で広がるビジネス・チャンス」
UFJ 5 1 5 5 63 ( 1 4 2 64 2 65 3 64 65 1 4 66 1 64 3 10 IT 5 UFJ 1 000 3 250 IPO 600 100 6 100 6 1 71 65 4 4.1 1 000 1 000 1 000 997 997 1 2 1 2 1 1 3 1 7 70 997 3 4 20 1 S S C C C C 7 7 SOHO 7 230 12
01-3 目次 .xls
119 6 (170 ) 5 4 3 2 1 F F WC -1-2 -1-2 C C A P D 612 (1B) 613 (1B) 615 (1B) 616 (1B) 617 4B 611 B 610 B 608 B 607 B 606 B 605 B 603 B 602 B 601 (1B) 512 (1B) 513 (1B) 515 (1B) 516 (1B) 517 4B 518 (1B)
日本医師会雑誌第131巻第10号
B C 100 12 11 13 3 C 4 C Q&A B C 54 B B B B Q&A B B HBV 20 HBV B B B B HBV HBV HBV HBV 2 HBV HBV HBV A HBV HBV HBV HBV HBV Q37 HBV HBV HBV 1015 B B B Q51 B HBV B B HBV B HBV HBV HBV B B B HBV B HBV HBV
88 1A AB 1.????,. () 200 A 100,,,.. (,, )..,,,,,,,,,,, [], [ ], [ ],,, [ ],, [ ], [],.. 7
![88 1A AB 1.????,. () 200 A 100,,,.. (,, )..,,,,,,,,,,, [], [ ], [ ],,, [ ],, [ ], [],.. 7](/thumbs/91/104739061.jpg "88 1A AB 1.????,. () 200 A 100,,,.. (,, )..,,,,,,,,,,, [], [ ], [ ],,, [ ],, [ ], [],.. 7")
87 --I 1A09021 1.0 1 2 AB 1-35,,,, () 20 -- 300 A 100 1 2 3,,,,,, 1 4 16 - furukubo-tokunaga.gm@u.tsukuba.ac.jp [] 2 4 23 - [] 3 5 7 kinaba@shimoda.tsukuba.ac.jp 4 5 14 sasakura@kurofune.shimoda.tsukuba.ac.jp
11 10 712 12 10 21 21 1024 Division of Public Health) ()()( )(Ph.D) 21
11 10 712 12 10 21 21 1024 Division of Public Health) ()()( )(Ph.D) 21 1 218 2 3 113 218 13 33039 388 29164 30 4929 28 16 413 16 13 5 24 6 1 2 121317 3 1 2 3 4 () () 30,000 (120235) 430() 1 245 3 11121317
untitled
3 218 ( ) 3 : 9 4TEEN () : 50 : : 2 125 153 SCAN KYOTO 1 190 190 3 16 1985 12 123 520 4 20 5 6 p.131 (p.511) 7 8 9 14 14 14 TEEN 10 TEEN14 11 12 25 13 D-51 14 120 10 15 50 50 15 50 2005 2055 50 50 50 16
<91E F193FA967B97D58FB B2D8FB4985E8F572E696E6464>
36 35 12 10 4 1 1300 1330 26 10 5 1 1330 1400 26 10 4 1 1400 1430 10 5 1 1400 1430 10 4 1 1430 1530 1 10 5 1 1430 1530 2 10 4 1 1100 1130 EL-1 1 10 4 2 1100 1130 EL-2 2 10 4 2 1500 1530 EL-3 3 2015 10
(CN)
ONY CN ( ) (CN) ONY VAIO o-net ony Plaza Edy 1 1 1946 0 1955 CG( ) 1979 3 1986 10 199 3 9.3 1 3000 900 13 4 1988 CB CB ( ME)1989 ( PE) 1993 ME 50 (CE) 1995 1996 (o-net) 1997 001 P P, P P b a + r + r P
HPB16_表1-表4.ai
03-5324-762406-6886-9300 03-5324-760806-6886-8218 03-5324-760606-6886-5035 http://just-hpb.jp/ Contents 4988637153787 4988637153794 4988637153930 4988637153947 41 4988637153800 4988637153848 4988637153954
EPSON LP-S7000 セットアップガイド
h h h h h h h h h h h h h h h abc ade o n A A B o C F D G E o H B G n K I L M I K J o o C A D B E F G h h h h h h h abc ade B ade A C D F E G A C h ade A C D B o ade E G H F G I F J M K N L O A B n C P
,938,235 3,876,091 3,805,600 3,704,298 3,673, , , , , , ,903
14 1 2.49 8% 1.41 1% 4.65 8% 2.24 1-1 14 1652 1.9 524 9.8% 1-2 5 55.2 912-1- 44.8 740 30 204 22.4 20 210 28.4 1-3 10 11 12 13 14 3,938,235 3,876,091 3,805,600 3,704,298 3,673,550 920,928 917,902 885,065
評価結果報告書の概要版（平成20年度）
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76
(%) 6. 5. 4. 3. 2. 1.. -1. -2. -3. -4. -5. 21/1-3 22/1-3 23/1-3 24/1-3 18, 17, 16, 15, 1 92 84 76 14, 68 13, 6 12, 52 11, 44 1, 9, 8, 7, 36 28 2 22/1 22/7 23/1 23/7 ( 1 FACT BOOK 24 2 14, 12, 1, 8, 6,
1 1 (1) 1 1 1 (2) 1 (3) 3 3 4 4 2 6 (1) 6 (2) 6 6 6 7 3 7 (1) 7 7 9 10 10 11 (2) 12 12 14 16 (3) 17 17 18 (4) 18 18 18
1 1 (1) 1 1 1 (2) 1 (3) 3 3 4 4 2 6 (1) 6 (2) 6 6 6 7 3 7 (1) 7 7 9 10 10 11 (2) 12 12 14 16 (3) 17 17 18 (4) 18 18 18 ( ) 20 10 26 39 1 2 ( ) 3 338 4 5 6 22 10 7 50 60 8 600 400 600 400 9 10 454 11 45
1 GP 2000p. 24. 45 11 12 46 1 1 1945 1956 1937 15,230 1948 16,852 3 1968 2
1! 1945 9 GHQ 1,500 1 GP 2000p. 24. 45 11 12 46 1 1 1945 1956 1937 15,230 1948 16,852 3 1968 2 1956 1960 278,002 1946 1947 3 5 8 3 1950 1955 5 1949 133 1957 56 5 GHQ 4 8 1946 TM 1950 52 3 GHQ 1950 3 5
untitled
1 2 1 1 2 3 1 2 1 2 4 0,76 4 5 0,1 1970 1974 1993 6 7 8 9 4 1920 10 1960 1971 ( ) IC 11 1980 1990 1992 1987 0,269 1996 0,023 2001 2002 1996 1996 1 98 27 70 1 3 7 12 2003 63 2 13 3 5 1 13 5 14 2 14 2 14
- 1 -
- 1 - HIV cmc cmc - 2 - cmc() ( ) 5-3 - - 4 - (1) (2) (3) ( ) - 5 - 0537-73-2662 0537-35-2971 0548-63-1251 9 00 16 00-6 - - 7 - 2 3 4 5 6 1,328 1,848 2,368 2,888 3,408-8 - - 9 - - 10 - - 11 - 3-12 - (